{"title":"Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancer.","authors":"Shimon Slavin","doi":"10.1016/j.medj.2024.11.005","DOIUrl":null,"url":null,"abstract":"<p><p>Although immunotherapy holds significant promise for treating drug-resistant cancers, currently available procedures are rarely curative. A new type of cell-mediated immunotherapy based on anticancer targeting activated mismatched cancer killer cells (ATACK) has demonstrated better efficacy and curative potential in preclinical animal models and in a pilot compassionate clinical study.</p>","PeriodicalId":29964,"journal":{"name":"Med","volume":"6 1","pages":"100552"},"PeriodicalIF":12.8000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Med","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.medj.2024.11.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Although immunotherapy holds significant promise for treating drug-resistant cancers, currently available procedures are rarely curative. A new type of cell-mediated immunotherapy based on anticancer targeting activated mismatched cancer killer cells (ATACK) has demonstrated better efficacy and curative potential in preclinical animal models and in a pilot compassionate clinical study.
期刊介绍：
Med is a flagship medical journal published monthly by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Cancer Cell, and Cell Reports Medicine. Our mission is to advance clinical research and practice by providing a communication forum for the publication of clinical trial results, innovative observations from longitudinal cohorts, and pioneering discoveries about disease mechanisms. The journal also encourages thought-leadership discussions among biomedical researchers, physicians, and other health scientists and stakeholders. Our goal is to improve health worldwide sustainably and ethically.
Med publishes rigorously vetted original research and cutting-edge review and perspective articles on critical health issues globally and regionally. Our research section covers clinical case reports, first-in-human studies, large-scale clinical trials, population-based studies, as well as translational research work with the potential to change the course of medical research and improve clinical practice.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
